OpenEvidence hits a $12B valuation, with a new round led by Thrive, DST

The VCs who have backed OpenEvidence are apparently not worried about new health-related products from OpenAI and Anthropic.

Wednesday, the beginning he announced that it raised an additional $ 250 million in Series D funding at a cost of $ 12 billion, led by Thrive Capital and DST.

That’s more than double its last amount in October: $200 million per $ 6 billion, led by GV. It has now raised $700 million, the company says, from backers including Sequoia, Nvidia, Kleiner Perkins, Blackstone, Bond, Craft Ventures, Mayo Clinic, and others.

OpenEvidence is an AI-powered medical platform, similar to what WebMD was on the previous generation of the Internet, but focused on doctors. This makes it competitive Anthropic’s Claude for Healthcarewhich is designed for patients, payers, and providers, where New ChatGPT Health it is very consumer oriented.

The company says the free, ad-supported platform delivered 18 million medical recommendations from certified medical professionals in the US in December alone. This compares to about 3 million searches per month a year ago. It also reported more than $100 million in revenue.